Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SciSparc Ltd. ( (SPRC) ) just unveiled an update.
On June 24, 2025, SciSparc Ltd. announced a 1-for-21 reverse share split of its ordinary shares, effective at the market open on July 3, 2025. This move, approved by shareholders in October 2024, will reduce the number of outstanding shares from approximately 11.2 million to 534,600, with no change in shareholders’ ownership percentages. The reverse split aims to adjust the share price and potentially improve the company’s market position on the Nasdaq Capital Market.
More about SciSparc Ltd.
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system. The company is engaged in drug development programs based on cannabinoid pharmaceuticals, including treatments for Tourette Syndrome, Alzheimer’s disease, autism, and status epilepticus. Additionally, SciSparc holds a controlling interest in a subsidiary that sells hemp seeds’ oil-based products on Amazon.
Average Trading Volume: 2,053,691
Technical Sentiment Signal: Sell
Current Market Cap: $3.32M
For detailed information about SPRC stock, go to TipRanks’ Stock Analysis page.